Humana Inc. $HUM Shares Sold by PKO Investment Management Joint Stock Co

PKO Investment Management Joint Stock Co lowered its position in Humana Inc. (NYSE:HUM) by 62.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,800 shares of the insurance provider’s stock after selling 3,000 shares during the quarter. PKO Investment Management Joint Stock Co’s holdings in Humana were worth $468,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in HUM. Focus Partners Wealth grew its stake in Humana by 104.2% during the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock worth $1,701,000 after buying an additional 3,281 shares during the period. Swedbank AB lifted its holdings in shares of Humana by 5.3% during the 2nd quarter. Swedbank AB now owns 100,397 shares of the insurance provider’s stock valued at $24,545,000 after acquiring an additional 5,032 shares in the last quarter. Bank of Nova Scotia lifted its holdings in shares of Humana by 219.3% during the 2nd quarter. Bank of Nova Scotia now owns 242,385 shares of the insurance provider’s stock valued at $59,258,000 after acquiring an additional 166,475 shares in the last quarter. Voya Investment Management LLC boosted its position in Humana by 7.7% during the 1st quarter. Voya Investment Management LLC now owns 45,190 shares of the insurance provider’s stock worth $11,957,000 after purchasing an additional 3,221 shares during the period. Finally, Ninety One UK Ltd acquired a new stake in Humana in the 3rd quarter valued at $18,613,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on HUM. Sanford C. Bernstein restated an “outperform” rating and set a $344.00 price objective on shares of Humana in a research note on Tuesday, January 6th. Barclays reiterated an “underperformer” rating on shares of Humana in a report on Monday, January 5th. Mizuho boosted their price target on Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Morgan Stanley restated an “underperform” rating on shares of Humana in a report on Thursday, December 18th. Finally, Wolfe Research dropped their price objective on shares of Humana from $313.00 to $300.00 and set an “outperform” rating on the stock in a research note on Thursday, November 20th. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $292.05.

Humana Trading Down 1.0%

Shares of HUM opened at $273.96 on Wednesday. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The stock has a 50-day moving average price of $254.06 and a 200 day moving average price of $263.12. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The company has a market capitalization of $32.95 billion, a P/E ratio of 25.68, a P/E/G ratio of 2.28 and a beta of 0.45.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.Humana’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business earned $4.16 EPS. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s dividend payout ratio is currently 33.18%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.